Literature DB >> 29142496

Precipitous Resolution of Type-A Intramural Hematoma with Medical Management in a Patient with Metastatic Stage 4 Renal Cell Carcinoma.

Camilo A Velasquez1, Syed Usman Bin Mahmood1, Mohammad A Zafar1, Adam J Brownstein1, Ayman Saeyeldin1, Bulat A Ziganshin1,2, John A Elefteriades1.   

Abstract

Intramural hematoma (IMH) is a variant form of aortic dissection characterized by involvement of the aortic media without the presence of an overt intimal flap. Surgical extirpation is the standard of care for type-A IMH in the Western world. However, a conservative approach with anti-impulse therapy has been advocated especially in Japan as a viable alternative. Here, we report a case of an elderly male patient with a history of metastatic stage 4 renal cell carcinoma who was treated with anti-impulse therapy for an acute type-A IMH. Blood pressure stabilization and continuous monitoring resulted in complete resolution of the IMH within 6 days. This report illustrates how immediate medical management in patients with acute type-A IMH who are not surgical candidates can alleviate the progression or even lead to regression as early as 1 week after initiating anti-impulse therapy.

Entities:  

Keywords:  dissecting aneurysm; dissection; hematoma; intramural hematoma; medical therapy; resolution; type-A dissection

Year:  2017        PMID: 29142496      PMCID: PMC5685788          DOI: 10.1055/s-0037-1604333

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  16 in total

1.  Extremely rapid regression of aortic intramural hematoma.

Authors:  M Ohmi; K Tabayashi; Y Moizumi; T Komatsu; Y Sekino; C Goko
Journal:  J Thorac Cardiovasc Surg       Date:  1999-11       Impact factor: 5.209

Review 2.  Aortic intramural hematoma: aspects of pathogenesis 2011.

Authors:  J-K Song
Journal:  Herz       Date:  2011-09       Impact factor: 1.443

Review 3.  Systemic Therapy for Metastatic Renal-Cell Carcinoma.

Authors:  Toni K Choueiri; Robert J Motzer
Journal:  N Engl J Med       Date:  2017-01-26       Impact factor: 91.245

4.  Management of patients with intramural hematoma involving the ascending aorta.

Authors:  Yoshimasa Moizumi; Tsunehiro Komatsu; Naotaka Motoyoshi; Koichi Tabayashi
Journal:  J Thorac Cardiovasc Surg       Date:  2002-11       Impact factor: 5.209

5.  Long-term behavior of aortic intramural hematomas and penetrating ulcers.

Authors:  Alan S Chou; Bulat A Ziganshin; Paris Charilaou; Maryann Tranquilli; John A Rizzo; John A Elefteriades
Journal:  J Thorac Cardiovasc Surg       Date:  2015-09-16       Impact factor: 5.209

6.  Outcomes of medically treated patients with aortic intramural hematoma.

Authors:  Jae-Kwan Song; Hyun-Sook Kim; Jong-Min Song; Duk-Hyun Kang; Jong-Won Ha; Se-Joong Rim; Namsik Chung; Kee-Sik Kim; Seung Woo Park; Yong Jin Kim; Dae-Won Sohn
Journal:  Am J Med       Date:  2002-08-15       Impact factor: 4.965

Review 7.  Aortic dissection.

Authors:  Christoph A Nienaber; Rachel E Clough; Natzi Sakalihasan; Toru Suzuki; Richard Gibbs; Firas Mussa; Michael P Jenkins; Matt M Thompson; Arturo Evangelista; James S M Yeh; Nicholas Cheshire; Ulrich Rosendahl; John Pepper
Journal:  Nat Rev Dis Primers       Date:  2016-07-21       Impact factor: 52.329

8.  Medical and Surgical Management of a Descending Aorta Penetrating Atherosclerotic Ulcer and Associated Ascending Intramural Hematoma.

Authors:  Matthew C Henn; Christopher P Lawrance; Alan C Braverman; Luis Sanchez; Jennifer S Lawton
Journal:  Aorta (Stamford)       Date:  2014-04-01

Review 9.  Acute aortic syndrome.

Authors:  Joel S Corvera
Journal:  Ann Cardiothorac Surg       Date:  2016-05

10.  Midterm follow-up of penetrating ulcer and intramural hematoma of the aorta.

Authors:  Shawn L Tittle; Raymond J Lynch; Patricia E Cole; Harsimran S Singh; John A Rizzo; Gary S Kopf; John A Elefteriades
Journal:  J Thorac Cardiovasc Surg       Date:  2002-06       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.